Palmer M K, Lythgoe J P, Smith A
Br J Surg. 1982 Dec;69(12):697-8. doi: 10.1002/bjs.1800691203.
Data relating to 1022 patients with early breast cancer who were entered into a clinical trial have been analysed to assess the importance of various factors in predicting prognosis. Clinical stage was the major determinant of prognosis, and in each stage patients with a breast tumour 2 cm or less in maximum diameter had a significantly better survival than patients with larger tumours. Patients aged between 40 and 49 years and premenopausal patients had relatively favourable prognosis. Site of the tumour within the breast, whether it was situated on the left or the right side, the patient's martial status and the number of pregnancies did not appear to have any influence.
对参与一项临床试验的1022例早期乳腺癌患者的数据进行了分析，以评估各种因素在预测预后方面的重要性。临床分期是预后的主要决定因素，在每个分期中，最大直径2厘米或更小的乳腺肿瘤患者的生存率明显高于肿瘤较大的患者。年龄在40至49岁之间的患者和绝经前患者的预后相对较好。肿瘤在乳房内的位置、位于左侧还是右侧、患者的婚姻状况以及怀孕次数似乎没有任何影响。
